Using a melanoma-associated vitiligo (MAV) mouse model, we recently demonstrated that after tumor removal, melanocyte-specific CD8 TRM cells develop within the skin of vitiligo-affected mice and are necessary and sufficient for durable anti-melanoma protection (12). Here, CD8A is linked to neoplasm.